CANNABIS OIL

Cannabis Treatment Shows Promise for Easing Dementia Agitation 0
- CANNABIS OIL
- July 14, 2026
A small clinical trial presented this week suggests that a carefully dosed combination of THC and CBD may significantly ease agitation in people with advanced dementia. In the 12‑week study of 120 hospice-eligible patients, nearly 90 percent of those receiving the cannabinoid treatment saw agitation decrease, compared with less than a quarter in the placebo
READ MORE
THC Drinks Surge in Popularity as New Review Highlights Standouts 0
- CANNABIS OIL
- July 7, 2026
The rapidly expanding market for THC-infused beverages is drawing curious consumers—and confusion—according to a recent review by the Atlanta Journal-Constitution. After sampling dozens of options, the writer identified clear winners in a crowded field now appearing in bottle shops and even gas stations. Top honors went to Cycling Frog for its balanced CBD-to-THC ratios and
READ MORE
Virginia Reaches Deal to Launch Recreational Marijuana Market by 2027 0
- CANNABIS OIL
- June 16, 2026
Virginia Gov. Abigail Spanberger and Democratic lawmakers have reached a long-awaited compromise to establish a regulated recreational marijuana market, set to launch on July 1, 2027. The agreement, detailed in the state’s pending budget, aims to replace the illicit cannabis trade with a structured system emphasizing public safety and consumer protection. Under the plan, retail
READ MORE

CBD Gummies Gain Momentum in the Wellness Market 0
- CANNABIS OIL
- May 14, 2026
CBD gummies are rapidly emerging as a popular wellness product, offering a discreet and easy way to consume cannabidiol. Derived from hemp and free from psychoactive effects, these chewable supplements are commonly used to support sleep, stress relief, and recovery. Low-dose CBD products are available over the counter, provided they meet strict standards, including zero
READ MORE
Medical Marijuana Reclassified, But CBD Rules Largely Unchanged 0
- CANNABIS OIL
- May 5, 2026
Federal drug policy took a notable shift on April 23, when Acting U.S. Attorney General Todd Blanche ordered state-licensed medical marijuana moved from Schedule I to Schedule III, a category reserved for substances with “moderate to low” dependence risk. The change acknowledges growing public support for medical cannabis but stops short of altering federal rules
READ MORE
CBD and Hemp Seed Oil Linked to Better Jaw Function in MPD Patients 0
- CANNABIS OIL
- April 22, 2026
A new clinical trial has found that both cannabidiol (CBD) oil and hemp seed oil were associated with improved jaw function over time in patients with myofascial pain disorder (MPD) of the temporomandibular region. The randomized, double-blind, placebo-controlled study enrolled 54 adults with moderate to severe jaw pain, assigning them to either oral CBD or
READ MORE